NYQ·Healthcare·$1.2B·#139 / 520 in Healthcare
AVNS Avanos Medical, Inc.
59SPECULATIVE
CATEGORY BREAKDOWN
GROWTH3
QUALITY53
STABILITY96
VALUATION97
GOVERNANCE48
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+1.9%
3
> 50% strong
Gross Margin
Revenue retained after direct costs
50.5%
71
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
16.6%
87
< 25% strong
Price / Sales
Market cap relative to trailing revenue
1.6x
97
< 3x strong
Rule of 40
Growth rate plus operating margin
4
26
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
3.3%
26
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+1.3%
92
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE AVNS WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when AVNS's score changes by 5+ points.
DATA INFO
Last updated: Jul 1, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.